Saneca wins significant tablet development and manufacturing contract6 Mar 2018
The agreement includes the manufacture of 600 million enteric, chewable and film-coated tablets.
CDMO Saneca Pharma has renewed an agreement with Pharmascience, one of Canada’s largest pharmaceutical companies, for the manufacture and supply of prescription medicines in tablet form.
The agreement, which follows a successful GMP audit held in January 2018, includes the manufacture of 600 million enteric, chewable and film-coated tablets (RX medicines) per year. It will also involve R&D and laboratory analyses related to existing and emerging formulations, as well as technical support in delivery to the Canadian market.
Markus Saal, sales director at Saneca Pharma said: “Pharmascience is a big name in the pharmaceutical industry, so it’s great to work with them on a project of this size.
“Saneca Pharma produces a large number of tablets for customers every year and has a huge amount of expertise, especially in solid dose manufacturing. By delivering both development and manufacturing services, we’re also able to simplify the tech transfer process to commercial production and streamline our customers’ projects, saving time and costs.
“We’re confident we’ll be able to add value to this project by combining our in-depth knowledge and our wide range of capabilities.”
The substantial agreement consists of nine different stock keeping units (SKUs), covering a number of therapeutic areas.
Pierre Plante, sourcing director at Pharmascience said: “Saneca Pharma is well located in Europe and its experience in manufacturing solid dose products was a huge part of the reason we selected them as our outsourcing partner for this project.
“Its comprehensive tech-transfer offering was also interesting for us. We look forward to continuing to develop our partnership with Saneca as we move into 2018.”
New gene therapy manufacturing facility for Orchard Therapeutics
13 Dec 2018
Enhances company's capacity to develop and deliver lentiviral vector and gene-corrected hematopoetic stem cells for wide range of diseases on a global scale.Read more
WuXi AppTec expands site in California for pharmaceutical R&D services
13 Dec 2018
Expanded facility will establish a center of excellence in screening, discovery biology, pharmacology, and small molecule process R&D including Phase I GMP manufacturing.Read more
Cambrex expands analytical capabilities
12 Dec 2018
The $1 million investment will assist in getting new products to commercial launch faster.Read more
Future-oriented packaging concepts from Sanner
11 Dec 2018
Company will showcase a range of packaging solutions, from desiccant and customized packaging to smart packaging solutions, at Pharmapack.Read more
One month on: medical cannabis is still taboo despite change in law
11 Dec 2018
Restrictive guidelines have led many to buy CBD products online, leading to a boom in production with many products going to market without sufficient quality control.Read more
SGS to expand bioanalytical testing capabilities
10 Dec 2018
The €3.5 million investment in equipment, facilities and expert staff will significantly increase the capabilities at the site to match increasing demand and shorten processes for pharmaceutical clients.Read more
MIT engineers repurpose wasp venom as an antibiotic drug
9 Dec 2018
Altered peptides from a South American wasp’s venom can kill bacteria but are nontoxic to human cells.Read more
Spanish CDMO working ahead of EU serialisation deadline
6 Dec 2018
Company now able to serialise commercial batches manufactured by them for clients; it can also offer standalone serialisation services as an outsourcing partner.Read more
Fluidic Analytics raises $31m to launch new lab tools and unlock biology behind major diseases
5 Dec 2018
The financing will power the global commercial launch of the company's Fluidity One system.Read more
OnDosis and Recipharm partner to advance a novel treatment regimen for ADHD
4 Dec 2018
The new treatment will leverage OnDosis’ proprietary technology, which integrates oral drugs in form of micro units and individualised dosing, in a handheld device.Read more
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation